Literature DB >> 11751668

Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty.

Z S Kyriakides1, S Psychari, N Chrysomallis, M Georgiadis, E Sbarouni, D T Kremastinos.   

Abstract

OBJECTIVE: To test whether type II diabetes prevents the recruitment of collaterals and the normal reduction of myocardial ischaemia on repeated balloon inflations during coronary angioplasty.
METHODS: Two groups of patients were studied. A collateral circulation group consisted of 56 patients, 18 diabetic and 38 non-diabetic. All underwent a minimum of three balloon inflations. A pressure guide wire was used for the measurement of coronary wedge pressure (mm Hg). The angioplasty protocol was repeated in another group of 57 patients (myocardial ischaemia group) using both surface and intracoronary ECGs to assess myocardial ischaemia.
RESULTS: In diabetic patients, mean (SD) coronary wedge pressure was 35 (12) mm Hg during the first balloon inflation, 39 (15) mm Hg during the second (p < 0.05 v first inflation), and 42 (17) mm Hg during the third (p < 0.05 v first inflation); in non-diabetic patients the respective values were 36 (16), 37 (16), and 37 (16) mm Hg (F = 4.73, p = 0.01). The ratio of coronary wedge pressure to mean arterial pressure in diabetic patients in the three balloon inflations was 0.33 (0.11), 0.36 (0.13), and 0.39 (0.15), respectively (p < 0.05 v the first inflation); and in non-diabetic patients it was 0.33 (0.15), 0.34 (0.15), and 0.35 (0.15) (F = 1.92, p = 0.15). In the diabetic group the response was independent of the type of treatment. No difference between diabetic and non-diabetic patients was observed in the normal reduction of myocardial ischaemia on repeated balloon inflations.
CONCLUSIONS: Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during coronary angioplasty in single vessel disease, regardless of the type of antidiabetic treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11751668      PMCID: PMC1766967          DOI: 10.1136/heart.87.1.61

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Diabetes, coronary heart disease and sulphonylureas-not the final word.

Authors:  D J Betteridge; L Close
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

2.  Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

Authors:  A Klamann; P Sarfert; V Launhardt; G Schulte; W H Schmiegel; M A Nauck
Journal:  Eur Heart J       Date:  2000-02       Impact factor: 29.983

3.  Effects of factors predisposing to atherosclerosis on formation of coronary collateral vessels.

Authors:  R A Heinle; R I Levy; R Gorlin
Journal:  Am J Cardiol       Date:  1974-01       Impact factor: 2.778

4.  Functional importance of the human coronary collateral circulation.

Authors:  R H Helfant; P S Vokonas; R Gorlin
Journal:  N Engl J Med       Date:  1971-06-10       Impact factor: 91.245

Review 5.  The coronary collateral circulation: determinants and functional significance in ischemic heart disease.

Authors:  P E Newman
Journal:  Am Heart J       Date:  1981-09       Impact factor: 4.749

6.  Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty.

Authors:  Z S Kyriakides; D T Kremastinos; T M Kolettis; A Tasouli; A Antoniadis; D J Webb
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

7.  Prognosis of patients with diabetes mellitus after acute myocardial infarction.

Authors:  J W Smith; F I Marcus; R Serokman
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

8.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

Authors:  K P Rentrop; M Cohen; H Blanke; R A Phillips
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty.

Authors:  P L Friedman; T L Shook; J M Kirshenbaum; A P Selwyn; P Ganz
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.